FrankASinicropeMDFACP
Gastroenterology • Rochester, MNGastrointestinal Cancer, Hepatology & Liver Transplantation
Professor, Internal Medicine and Oncology, Mayo Medical School
Dr. Sinicrope is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 1st St Sw
Rochester, MN 55905Phone+1 507-284-2511
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1996 - 1997
University of ChicagoFellowship, Gastroenterology, 1989 - 1992
Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1986 - 1988
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
Certifications & Licensure
CA State Medical License 1991 - Present
MN State Medical License 2002 - 2025
TX State Medical License 1992 - 2003
IL State Medical License 1985 - 1993- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer Start of enrollment: 2004 Feb 01
- Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum Start of enrollment: 2004 Dec 01
- Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer Start of enrollment: 2009 Aug 20
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsBRAF + EGFR +/- MEK inhibitors after immune checkpoint inhibitors in BRAF V600E mutated and deficient mismatch repair or microsatellite instability high metastatic col...Margherita Ambrosini, David Tougeron, Dominik Modest, Rosine Guimbaud, Scott Kopetz
European Journal of Cancer. 2024-10-01 - Immune checkpoint blockade: timing is everything.Frank A Sinicrope, Mary Jo Turk
Journal for Immunotherapy of Cancer. 2024-08-28 - 3 citationsFerroptosis: Biology and Role in Gastrointestinal Disease.Juan-José Escuder-Rodríguez, Deguang Liang, Xuejun Jiang, Frank A Sinicrope
Gastroenterology. 2024-07-01
Journal Articles
- MiR-139-5p as a Novel Serum Biomarker for Recurrence and Metastasis in Colorectal CancerFrank A Sinicrope, Steven R Alberts, Ajay Goel, Nature
Lectures
- Relative contribution of clinical and molecular features to outcome within low and high risk T and N groups in stage III colon cancer (CC).2019 ASCO Annual Meeting - 6/1/2019
- Randomized trial of standard chemotherapy alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient mismatch repai...2019 ASCO Annual Meeting - 6/1/2019
- Validation of tumor infiltrating lymphocytes (TIL) and tumor budding as predictors of prognosis in patients with stage III colon cancers treated in a FOLFOX-based adju...2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018
- Join now to see all
Press Mentions
Mayo Clinic Expert Calls for Public Health Measures to Improve Diet, Reduce Cancer RiskApril 27th, 2022- Tumor Cell PD-L1 May Mediate Sensitivity to Chemotherapy in Colorectal Cancer TreatmentJuly 2nd, 2021
WVU Health System to Manage 203-Bed HospitalDecember 18th, 2020- Join now to see all
Grant Support
- Translational Research In Colon Cancer Prevention &TreatmentNational Cancer Institute2009–2011
- Polyphenon E For The Chemoprevention Of Colorectal CancerNational Cancer Institute2008–2011
- Aberrant Crypt FOCI As A Biomarker For ChemopreventionNational Cancer Institute2006–2009
- Clinical Significance Of Apoptosis In Colon CancerNational Cancer Institute2004–2006
- Clinical Significance Of Apoptosis In Colon CancerNational Cancer Institute2003
- Beta-Catenin And RAR Interact At The PKC Alpha PromoterNational Institute Of Diabetes And Digestive And Kidney Diseases2002
- A Three Arm Phase II Chemoprevention Trial In AdenomatouDivision Of Cancer Prevention And Control1999–2000
- Calcium And Aspirin Prevention TrialNational Cancer Institute1997
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
